We are live on
!
Find out more
LSV Asset Management Portfolio holdings
AUM
$55.1B
1-Year Est. Return
45.38%
This Fund
S&P 500
This Quarter
Est. Return
+1.37%
1 Year Est. Return
+45.38%
3 Year Est. Return
+99.45%
5 Year Est. Return
+122.42%
10 Year Est. Return
+379.58%
AUM
$56.1B
AUM Growth
+$1.28B
(+2.3%)
Cap. Flow
+$954M
Cap. Flow
% of AUM
1.7%
Top 10 Holdings %
Top 10 Hldgs %
15.82%
Holding
1,077
New
43
Increased
378
Reduced
318
Closed
65
Avg Time Held
10.2
quarters
Top 10 Avg Time Held
10.6
quarters
Top 20 Avg Time Held
9.1
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
OA
Orbital ATK, Inc.
OA
|
+$137M |
| 2 |
Lazard
LAZ
|
+$130M |
| 3 |
Biogen
BIIB
|
+$109M |
| 4 |
Walt Disney
DIS
|
+$77.6M |
| 5 |
SCG
Scana
SCG
|
+$74.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$232M |
| 2 |
Quest Diagnostics
DGX
|
+$163M |
| 3 |
United Therapeutics
UTHR
|
+$98.8M |
| 4 |
Phillips 66
PSX
|
+$85M |
| 5 |
Hewlett Packard
HPE
|
+$59.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.13% |
| 2 | Technology | 13.83% |
| 3 | Healthcare | 13.4% |
| 4 | Industrials | 10.8% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Johnson & Johnson
JNJ
$635B
| $1.33B | 2.36% |
10,034,023
-71,654
| -0.7% | -$9.14M |
2013 Q2
16 quarters
|
|
2
JPMorgan Chase
JPM
$889B
| $1.13B | 2.01% |
12,368,751
+15,857
| +0.1% | +$1.37M |
2013 Q2
16 quarters
|
|
3
Pfizer
PFE
$162B
| $1.12B | 1.99% |
35,072,453
+209,852
| +0.6% | +$6.62M |
2013 Q2
16 quarters
|
|
4
Citigroup
C
$221B
| $871M | 1.55% |
13,020,272
+131,839
| +1% | +$8.09M |
2013 Q2
16 quarters
|
|
5
Cisco
CSCO
$455B
| $859M | 1.53% |
27,453,460
+134,162
| +0.5% | +$4.37M |
2013 Q2
16 quarters
|
|
6
AT&T
T
$154B
| $779M | 1.39% |
27,344,968
-1,290,084
| -5% | -$38M |
2013 Q2
16 quarters
|
|
7
Intel
INTC
$536B
| $775M | 1.38% |
22,966,250
+181,254
| +0.8% | +$6.49M |
2013 Q2
16 quarters
|
|
8
ExxonMobil
XOM
$706B
| $702M | 1.25% |
8,692,128
-109,795
| -1% | -$8.98M |
2013 Q2
16 quarters
|
|
9
Bank of America
BAC
$381B
| $694M | 1.24% |
28,602,694
+455,819
| +2% | +$10.6M |
2013 Q2
16 quarters
|
|
10
Merck
MRK
$359B
| $629M | 1.12% |
10,277,755
+115,392
| +1% | +$7.02M |
2013 Q2
16 quarters
|
|
11
Valero Energy
VLO
$126B
| $612M | 1.09% |
9,076,859
+366,009
| +4% | +$23.7M |
2013 Q2
16 quarters
|
|
12
Amgen
AMGN
$226B
| $596M | 1.06% |
3,460,689
+158,775
| +5% | +$25.8M |
2013 Q2
16 quarters
|
|
13
Boeing
BA
$150B
| $595M | 1.06% |
3,006,858
+21,804
| +0.7% | +$4.06M |
2013 Q2
16 quarters
|
|
14
Public Service Enterprise Group
PEG
$35.2B
| $593M | 1.06% |
13,796,550
+27,791
| +0.2% | +$1.23M |
2013 Q2
16 quarters
|
|
15
Verizon
VZ
$177B
| $573M | 1.02% |
12,829,293
-182,391
| -1% | -$8.5M |
2013 Q2
16 quarters
|
|
16
Chevron
CVX
$422B
| $513M | 0.91% |
4,921,751
-8,950
| -0.2% | -$948K |
2013 Q2
16 quarters
|
|
17
Travelers Companies
TRV
$77.5B
| $513M | 0.91% |
4,052,335
-94,090
| -2% | -$11.6M |
2013 Q2
16 quarters
|
|
18
Elevance Health
ELV
$91.6B
| $510M | 0.91% |
2,712,789
-13,471
| -0.5% | -$2.42M |
2013 Q2
16 quarters
|
|
19
Everest Group
EG
$14.3B
| $499M | 0.89% |
1,958,437
-4,408
| -0.2% | -$1.09M |
2013 Q2
16 quarters
|
|
20
AbbVie
ABBV
$495B
| $481M | 0.86% |
6,628,586
+295,076
| +5% | +$19.8M |
2013 Q2
16 quarters
|
|
21
Allstate
ALL
$58.8B
| $467M | 0.83% |
5,278,650
+6,670
| +0.1% | +$565K |
2013 Q2
16 quarters
|
|
22
FirstEnergy
FE
$26.2B
| $421M | 0.75% |
14,438,631
+385,978
| +3% | +$11.5M |
2014 Q1
13 quarters
|
|
23
FedEx
FDX
$69.1B
| $411M | 0.73% |
1,890,000
-41,411
| -2% | -$8.18M |
2013 Q2
16 quarters
|
|
24
Regions Financial
RF
$23.3B
| $404M | 0.72% |
27,572,058
+295,476
| +1% | +$4.16M |
2013 Q2
16 quarters
|
|
25
DELISTED
Discover Financial Services
DFS
| $403M | 0.72% |
6,472,520
+103,554
| +2% | +$6.41M |
2013 Q2
16 quarters
|
|
Similar funds
HF
LSV Asset Management's Q2 2017 Portfolio in Review
As of Q2 2017, LSV Asset Management held 1,077 positions worth $56.1B, up 2.3% from $54.9B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
LSV Asset Management's Q2 2017 filing shows 43 new, 378 increased, 318 reduced and 65 closed positions. Its largest new stake was DXC Technology: 978,007 shares worth $64.9M. The largest sale was Marathon Petroleum, an estimated $232M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 24% a quarter earlier, followed by Technology and Healthcare.
- LSV Asset Management's largest Q2 2017 buy was DXC Technology: 978,007 shares worth $64.9M.
- LSV Asset Management added most to Orbital ATK, Inc. in Q2 2017, an estimated $137M increase.
- LSV Asset Management's biggest Q2 2017 reduction was Marathon Petroleum, cutting an estimated $232M.
- LSV Asset Management fully exited Select Medical in Q2 2017, selling an estimated $30.1M.
- LSV Asset Management's ten largest holdings make up 16% of its $56.1B portfolio in Q2 2017.
- LSV Asset Management opened 43 new positions and closed 65 in Q2 2017.
- LSV Asset Management's portfolio value rose 2.3% quarter-over-quarter to $56.1B.
Based on LSV Asset Management's 13F filing for Q2 2017, filed 9 Aug 2017.